A Case of Immune-Mediated Pneumonitis Associated With Dual Nivolumab and Ipilimumab Immunotherapy Treatment

被引：0

作者：

Al-Saghir, Tala ^{[1
]}

Suleiman, Noor ^{[1
]}

Goodman, Benjamin D. ^{[1
]}

Ferguson, Michael W. ^{[1
]}

Tejwani, Sheela ^{[2
]}

机构：

[1] Henry Ford Hlth Syst, Internal Med, Detroit, MI 48202 USA

[2] Henry Ford Hlth Syst, Med Oncol, Detroit, MI USA

来源：

CUREUS JOURNAL OF MEDICAL SCIENCE | 2023年 / 15卷 / 06期

关键词：

complications; immunotherapy; metastatic melanoma treatment; immune mediated pneumonitis; yervoy; opdivo; ipilimumab; nivolumab;

D O I：

10.7759/cureus.40792

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Nivolumab and ipilimumab are immunotherapy agents used in combination to treat metastatic melanoma and have proven to be efficacious. However, they have been linked to the development of immune-mediated inflammatory processes in various organ systems and tissues, including immune-mediated pneumonitis (IMP). This case report describes a 50-year-old female patient with metastatic melanoma who was treated with nivolumab and ipilimumab therapy and developed IMP as a complication. Despite treatment with steroids and infliximab, the patient's condition worsened, and she passed away due to respiratory compromise. This report emphasizes the potential for serious complications in patients receiving combination immunotherapy and highlights the importance of close monitoring and risk stratification, particularly in patients with underlying lung conditions.

引用

页数：4

共 10 条

[1] Interstitial lung diseases in the hospitalized patient [J].

Disayabutr, Supparerk ;

Calfee, Carolyn S. ;

Collard, Harold R. ;

Wolters, Paul J. .

BMC MEDICINE, 2015, 13

[2] Improved Survival with Ipilimumab in Patients with Metastatic Melanoma [J].

Hodi, F. Stephen ;

O'Day, Steven J. ;

McDermott, David F. ;

Weber, Robert W. ;

Sosman, Jeffrey A. ;

Haanen, John B. ;

Gonzalez, Rene ;

Robert, Caroline ;

Schadendorf, Dirk ;

Hassel, Jessica C. ;

Akerley, Wallace ;

van den Eertwegh, Alfons J. M. ;

Lutzky, Jose ;

Lorigan, Paul ;

Vaubel, Julia M. ;

Linette, Gerald P. ;

Hogg, David ;

Ottensmeier, Christian H. ;

Lebbe, Celeste ;

Peschel, Christian ;

Quirt, Ian ;

Clark, Joseph I. ;

Wolchok, Jedd D. ;

Weber, Jeffrey S. ;

Tian, Jason ;

Yellin, Michael J. ;

Nichol, Geoffrey M. ;

Hoos, Axel ;

Urba, Walter J. .

NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (08) :711-723

[3] Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma [J].

Larkin, J. ;

Chiarion-Sileni, V. ;

Gonzalez, R. ;

Grob, J-J ;

Rutkowski, P. ;

Lao, C. D. ;

Cowey, C. L. ;

Schadendorf, D. ;

Wagstaff, J. ;

Dummer, R. ;

Ferrucci, P. F. ;

Smylie, M. ;

Hogg, D. ;

Hill, A. ;

Marquez-Rodas, I. ;

Haanen, J. ;

Guidoboni, M. ;

Maio, M. ;

Schoffski, P. ;

Carlino, M. S. ;

Lebbe, C. ;

McArthur, G. ;

Ascierto, P. A. ;

Daniels, G. A. ;

Long, G. V. ;

Bastholt, L. ;

Rizzo, J. I. ;

Balogh, A. ;

Moshyk, A. ;

Hodi, F. S. ;

Wolchok, J. D. .

NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (16) :1535-1546

[4]

Larkin J, 2015, NEW ENGL J MED, V373, P23, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]

[5] Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies [J].

Naidoo, J. ;

Page, D. B. ;

Li, B. T. ;

Connell, L. C. ;

Schindler, K. ;

Lacouture, M. E. ;

Postow, M. A. ;

Wolchok, J. D. .

ANNALS OF ONCOLOGY, 2015, 26 (12) :2375-2391

[6] Pneumonitis in Patients Treated With Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy [J].

Naidoo, Jarushka ;

Wang, Xuan ;

Woo, Kaitlin M. ;

Iyriboz, Tunc ;

Halpenny, Darragh ;

Cunningham, Jane ;

Chaft, Jamie E. ;

Segal, Neil H. ;

Callahan, Margaret K. ;

Lesokhin, Alexander M. ;

Rosenberg, Jonathan ;

Voss, Martin H. ;

Rudin, Charles M. ;

Rizvi, Hira ;

Hou, Xue ;

Rodriguez, Katherine ;

Albano, Melanie ;

Gordon, Ruth-Ann ;

Leduc, Charles ;

Rekhtman, Natasha ;

Harris, Bianca ;

Menzies, Alexander M. ;

Guminski, Alexander D. ;

Carlino, Matteo S. ;

Kong, Benjamin Y. ;

Wolchok, Jedd D. ;

Postow, Michael A. ;

Long, Georgina V. ;

Hellmann, Matthew D. .

JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (07) :709-+

[7] Incidence of Programmed Cell Death 1 Inhibitor-Related Pneumonitis in Patients With Advanced Cancer A Systematic Review and Meta-analysis [J].

Nishino, Mizuki ;

Giobbie-Hurder, Anita ;

Hatabu, Hiroto ;

Ramaiya, Nikhil H. ;

Hodi, Stephen .

JAMA ONCOLOGY, 2016, 2 (12) :1607-1616

[8]

opdivohcp, 2022, IMM MED ADV REACT MA

[9] Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma [J].

Wolchok, J. D. ;

Chiarion-Sileni, V. ;

Gonzalez, R. ;

Rutkowski, P. ;

Grob, J. -J. ;

Cowey, C. L. ;

Lao, C. D. ;

Wagstaff, J. ;

Schadendorf, D. ;

Ferrucci, P. F. ;

Smylie, M. ;

Dummer, R. ;

Hill, A. ;

Hogg, D. ;

Haanen, J. ;

Carlino, M. S. ;

Bechter, O. ;

Maio, M. ;

Marquez-Rodas, I. ;

Guidoboni, M. ;

McArthur, G. ;

Lebbe, C. ;

Ascierto, P. A. ;

Long, G. V. ;

Cebon, J. ;

Sosman, J. ;

Postow, M. A. ;

Callahan, M. K. ;

Walker, D. ;

Rollin, L. ;

Bhore, R. ;

Hodi, F. S. ;

Larkin, J. .

NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (14) :1345-1356

[10] Immune-Related Adverse Events: Pneumonitis [J].

Zhong, Linda ;

Altan, Mehmet ;

Shannon, Vickie R. ;

Sheshadri, Ajay .

IMMUNOTHERAPY, 3RD EDITION, 2020, 1244 :255-269

← 1 →